Cite
HARVARD Citation
He, L. et al. (2015). The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
He, L. et al. (2015). The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].